Brian Brogie has more than 30 years of manufacturing, process

improvement and supplier management experience in highly regulated

industries, including medical devices

TUCSON, Ariz.--(BUSINESS WIRE)--#TotalArtificialHeart--SynCardia Systems, LLC (www.syncardia.com),

manufacturer of the world’s first and only FDA, Health Canada and CE

(Europe) approved Total Artificial Heart, announced today that Brian

Brogie has joined the company as Vice President of Manufacturing and

Facilities.

Brogie will oversee manufacturing of SynCardia’s product line, which

includes the commercially approved 70cc

Total Artificial Heart for smaller patients; the Companion

2 hospital driver for powering the Total Artificial Heart from

implant until the patient stabilizes; and the Freedom®

portable driver, a wearable power supply that allows clinically

stable patients to be discharged from the hospital.

“Brian has more than 30 years of experience, skills and knowledge in

manufacturing, project management, process improvement and supplier

management,” said Michael Garippa, President and CEO of SynCardia. “His

track record of success in highly regulated industries, including

medical devices, pharmaceuticals and aerospace, will help ensure that we

continue to provide hospitals around the world with the products they

need, when they need them, to save the lives of patients with end-stage

heart failure.”

Prior to joining SynCardia, Brogie served as Director of Manufacturing

for Gilead Sciences, Inc., where he led a team responsible for

manufacturing two injectable drug products and packaging 12 solid oral

dose products. Among his most critical duties were ensuring Current Good

Manufacturing Practice (cGMP) compliance, executing spending within a

$24 million manufacturing budget and facilitating the introduction of

new products to the company’s production line. Brogie previously held

similar positions with Oso BioPharmaceuticals and BF Goodrich Aerospace.

“Working for SynCardia is a once-in-a-lifetime opportunity,” said

Brogie. “No one else is doing what they do for heart failure patients,

and it’s an honor to join the team.”

CAUTION -- In the United States, the 50cc SynCardia temporary Total

Artificial Heart is an investigational device, limited by federal law to

investigational use.

About SynCardia Systems, LLC

Systems, LLC in Tucson, Ariz., is the privately-held manufacturer of

the world's first and only FDA, Health Canada and CE approved Total

Artificial Heart. For people suffering from end-stage heart failure

affecting both sides of the heart (biventricular failure), the SynCardia

temporary Total Artificial Heart is used as a bridge to transplant,

helping them survive until a matching donor heart becomes

available. SynCardia also manufactures the Freedom® portable driver,

which powers the SynCardia Total Artificial Heart and allows clinically

stable patients to be discharged from the hospital to enjoy life at home

while they wait for a heart transplant.

Follow SynCardia: Facebook | Twitter | LinkedIn | Google+

Contacts

SynCardia Systems, LLC

Janelle Drumwright, 520-547-7463